Back to Ensign Peak Advisors, Inc Ensign Peak Advisors, Inc

TNGXTNGX

Showing 3 of 15 quarters

Position history for Ensign Peak Advisors, IncEnsign Peak Advisors, Inc's holdings in Tango Therapeutics, Inc.

No. Ensign Peak Advisors exited its TNGX (Tango Therapeutics) position in Q1 2025. Its Q4 2024 13F listed 57,319 shares worth $177,116. Ensign Peak Advisors already held TNGX in its Q3 2021 13F, the earliest on record, and held it in 14 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$220,366

Total Shares Change

-28,619

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q1
Latest
Exited
0
-100.0%
$00.0%$1.37
0
2024-Q4
Increased
57,319
+100.3%
$177,1160.0%$3.09
37
2024-Q3
Decreased
28,619
-89.5%
$220,3660.0%$7.47
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used